Some patients may also experience reduced appetite and weight loss, although the amount of weight lost varies among individuals
RGAs model suggests that the second factor is the most important, leading insured groups to experience a lower mortality impact from AOMs than the general population
Porrini E, Ruggenenti P, Mogensen CE et al (2015) Non-proteinuric pathways in loss of renal function in patients with type 2 diabetes
Ramella A, Roda G, Pavlovic R, Dei Cas M, Casagni E, Mosconi G, et al
Plus, they slow down the digestive process, which can help you feel fuller for longer periods of time, ultimately reducing appetite and food intake, which can help support weight loss